Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
European Medicines Agency to review third and fourth generation combined oral contraceptives
Notice type:
3rd Party Publications
Date:
28/01/2013
Product name or type:
Third- and fourth-generation combined oral contraceptives
Problem Or Issue:
The European Medicines Agency (EMA) has been asked by France to review third and fourth generation combined oral contraceptives to determine whether there is a need to restrict the use of these medicines to women who cannot take other combined oral contraceptives. The EMA issued their intention to conduct that review today. See attached press release.
Background Information Or Related Documents:
European Medicines Agency to review third and fourth generation combined oral contraceptives Document
Further Information:
EMA to review third- and fourth-generation combined oral contraceptives
« Back
Date Printed: 13/05/2024